160 related articles for article (PubMed ID: 7883773)
1. Prognostic value of proliferating cell nuclear antigen and c-erbB-2 compared with conventional histopathological factors in breast cancer.
Schönborn I; Zschiesche W; Minguillon C; Spitzer E; Möhner M; Ebeling K; Grosse R
J Cancer Res Clin Oncol; 1995; 121(2):115-22. PubMed ID: 7883773
[TBL] [Abstract][Full Text] [Related]
2. Prognostic factors affecting disease-free survival rate following surgical resection of primary breast cancer.
Horita K; Yamaguchi A; Hirose K; Ishida M; Noriki S; Imamura Y; Fukuda M
Eur J Histochem; 2001; 45(1):73-84. PubMed ID: 11411868
[TBL] [Abstract][Full Text] [Related]
3. [C-erbB-2, EGF receptor, p53 and PCNA. The prognostic significance of recent tumor markers for lymph node negative breast cancer].
Schönborn I; Minguillon C; Lichtenegger W; Zschiesche W; Spitzer E
Geburtshilfe Frauenheilkd; 1995 Oct; 55(10):566-71. PubMed ID: 8543129
[TBL] [Abstract][Full Text] [Related]
4. Prognostic impact of cathepsin D and c-erbB-2 oncoprotein in a subgroup of node-negative breast cancer patients with low histological grade tumors.
Gaci Z; Bouin-Pineau MH; Gaci M; Daban A; Ingrand P; Métayé T
Int J Oncol; 2001 Apr; 18(4):793-800. PubMed ID: 11251176
[TBL] [Abstract][Full Text] [Related]
5. An immunohistochemical study of p53 with correlations to histopathological parameters, c-erbB-2, proliferating cell nuclear antigen, and prognosis.
Haerslev T; Jacobsen GK
Hum Pathol; 1995 Mar; 26(3):295-301. PubMed ID: 7890281
[TBL] [Abstract][Full Text] [Related]
6. C-erbB-2 and PCNA as prognostic indicators of long-term survival in breast cancer.
Kato T; Kameoka S; Kimura T; Nishikawa T; Kobayashi M
Anticancer Res; 2002; 22(2B):1097-103. PubMed ID: 12168907
[TBL] [Abstract][Full Text] [Related]
7. C-erbB-2 overexpression in primary breast cancer: independent prognostic factor in patients at high risk.
Schönborn I; Zschiesche W; Spitzer E; Minguillon C; Möhner M; Ebeling K; Grosse R
Breast Cancer Res Treat; 1994; 29(3):287-95. PubMed ID: 7914107
[TBL] [Abstract][Full Text] [Related]
8. C-erbB-2 onco-protein expression in breast cancer: relationship to tumour characteristics and short-term survival in Universiti Kebansaan Malaysia Medical Centre.
Sharifah NA; Lee BR; Clarence-Ko CH; Tan GC; Shiran MS; Naqiyah I; Rohaizak M; Fuad I; Tamil AM
Asian Pac J Cancer Prev; 2008; 9(4):663-70. PubMed ID: 19271345
[TBL] [Abstract][Full Text] [Related]
9. Proliferating cell nuclear antigen (pcna) and C-erbb-2 oncoprotein in breast-carcinoma with correlations to histopathological parameters and prognosis.
Haerslev T; Jacobsen G; Zedeler K
Oncol Rep; 1995 Jan; 2(1):99-105. PubMed ID: 21597698
[TBL] [Abstract][Full Text] [Related]
10. Prognostic and predictive value of c-erbB-2 overexpression in primary breast cancer, alone and in combination with other prognostic markers.
Sjögren S; Inganäs M; Lindgren A; Holmberg L; Bergh J
J Clin Oncol; 1998 Feb; 16(2):462-9. PubMed ID: 9469329
[TBL] [Abstract][Full Text] [Related]
11. The prognostic significance of epidermal growth factor receptor (EGFR), C-erbB-2, Ki-67 and PCNA expression in breast cancer.
Ioachim E; Kamina S; Athanassiadou S; Agnantis NJ
Anticancer Res; 1996; 16(5B):3141-7. PubMed ID: 8920782
[TBL] [Abstract][Full Text] [Related]
12. Integration of estrogen and progesterone receptors with pathological and molecular prognostic factors in breast cancer patients.
Gago FE; Tello OM; Diblasi AM; Ciocca DR
J Steroid Biochem Mol Biol; 1998 Dec; 67(5-6):431-7. PubMed ID: 10030692
[TBL] [Abstract][Full Text] [Related]
13. The prognostic significance of proliferating cell nuclear antigen in patients with lymph node-positive breast cancer.
Sheen-Chen SM; Eng HL; Chou FF; Chen WJ
Arch Surg; 1997 Mar; 132(3):264-7. PubMed ID: 9125025
[TBL] [Abstract][Full Text] [Related]
14. Prognostic value of proliferating cell nuclear antigen in lymph node-negative breast cancer patients.
Bianchi S; Paglierani M; Zampi G; Cardona G; Cataliotti L; Bonardi R; Zappa M; Ciatto S
Cancer; 1993 Jul; 72(1):120-5. PubMed ID: 8099532
[TBL] [Abstract][Full Text] [Related]
15. Multivariate analysis of DNA ploidy, p53, c-erbB-2 proteins, EGFR, and steroid hormone receptors for prediction of poor short term prognosis in breast cancer.
Eissa S; Khalifa A; el-Gharib A; Salah N; Mohamed MK
Anticancer Res; 1997; 17(2B):1417-23. PubMed ID: 9137508
[TBL] [Abstract][Full Text] [Related]
16. Prognosis of breast cancer: evidence for interaction between c-erbB-2 overexpression and number of involved axillary lymph nodes.
Mittra I; Redkar AA; Badwe RA
J Surg Oncol; 1995 Oct; 60(2):106-11. PubMed ID: 7564375
[TBL] [Abstract][Full Text] [Related]
17. Proliferating cell nuclear antigen in breast carcinomas. An immunohistochemical study with correlation to histopathological features and prognostic factors.
Haerslev T; Jacobsen GK
Virchows Arch; 1994; 424(1):39-46. PubMed ID: 7981902
[TBL] [Abstract][Full Text] [Related]
18. Prognostic indicators for breast cancer patients with one to three regional lymph node metastases, with special reference to alterations in expression levels of bcl-2, p53 and c-erbB-2 proteins.
Zhang GJ; Tsuda H; Adachi I; Fukutomi T; Yamamoto H; Hirohashi S
Jpn J Clin Oncol; 1997 Dec; 27(6):371-7. PubMed ID: 9437997
[TBL] [Abstract][Full Text] [Related]
19. The methodology of quantitation of microvessel density and prognostic value of neovascularization associated with long-term survival in Japanese patients with breast cancer.
Kato T; Kimura T; Ishii N; Fujii A; Yamamoto K; Kameoka S; Nishikawa T; Kasajima T
Breast Cancer Res Treat; 1999 Jan; 53(1):19-31. PubMed ID: 10206069
[TBL] [Abstract][Full Text] [Related]
20. Human breast cancer: prognostic significance of the c-erbB-2 oncoprotein compared with epidermal growth factor receptor, DNA ploidy, and conventional pathologic features.
Gasparini G; Gullick WJ; Bevilacqua P; Sainsbury JR; Meli S; Boracchi P; Testolin A; La Malfa G; Pozza F
J Clin Oncol; 1992 May; 10(5):686-95. PubMed ID: 1349034
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
